Infection is one of the leading causes of morbidity and mortality in systemic lupus
erythematosus (SLE). Bacterial infections are most frequent, followed by viral and fungal …

Viral and bacterial infections may serve as an environmental trigger for the development or
exacerbation of systemic lupus erythematosus (SLE) in the genetically predetermined …

Corticosteroids represent the most important and frequently used class of anti-inflammatory
drugs and are the reference therapy for numerous neoplastic, immunological and allergic …

Objective To conduct a systematic literature review (SLR) on the screening and prophylaxis
of opportunistic and chronic infections in autoimmune inflammatory rheumatic diseases …

Background Bacterial infections of the lung, skin, bloodstream and other tissues are
common in patients with systemic lupus erythematosus (lupus) and are often more severe …

OBJECTIVES: To present the systematic literature review (SLR), which formed the basis for
the European League Against Rheumatism (EULAR) evidence-based recommendations for …

Systemic lupus erythematosus (SLE) is an autoimmune multisystem disease with numerous
clinical manifestations. There is no consensus about the ideal oral management for this …

The incidence and severity of tuberculosis (TB) in patients with systemic lupus
erythematosus (SLE) varies greatly among different series. In addition, prospective data are …

Systemic lupus erythematosus (SLE) is known to occur in all populations across the globe.
In many respects SLE is similar across regions in its spectrum of clinical features, but the …

Infections are an important cause of morbidity and mortality in systemic lupus erythematosus
(SLE). Survival rates for SLE patients in developing countries are comparatively lower than …